Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSEPH STAFFORD

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1962847947
CMS profile
846344
Location
TEMPLE, TX

General Payments · PY2018–2024

$1,603.51

  • Reported across 73 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$647.62

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $567.63 31
Education $79.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $213.22 9
Abbott Laboratories $195.50 2
NOVARTIS PHARMACEUTICALS CORPORATION $159.17 20
Amgen Inc. $79.73 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $97.71 5
PY2019 $207.70 6
PY2020 $18.81 1
PY2021 $45.52 3
PY2022 $326.75 10
PY2023 $259.40 16
PY2024 $647.62 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $82.98 05/15/2024 Food and Beverage Undisputed 01/23/2026 1125362146 CMS
Abbott Laboratories $112.52 07/02/2024 Food and Beverage Undisputed 01/23/2026 1125362148 CMS
Amgen Inc. $79.73 06/26/2024 Food and Beverage Undisputed 01/23/2026 1111715472 CMS
AstraZeneca Pharmaceuticals LP $15.51 01/18/2024 Food and Beverage Undisputed 01/23/2026 1104366655 CMS
AstraZeneca Pharmaceuticals LP $79.99 02/15/2024 Education Undisputed 01/23/2026 1105560744 CMS
AstraZeneca Pharmaceuticals LP $17.86 02/15/2024 Food and Beverage Undisputed 01/23/2026 1105790604 CMS
AstraZeneca Pharmaceuticals LP $17.11 03/21/2024 Food and Beverage Undisputed 01/23/2026 1104299654 CMS
AstraZeneca Pharmaceuticals LP $16.25 04/01/2024 Food and Beverage Undisputed 01/23/2026 1105487737 CMS
AstraZeneca Pharmaceuticals LP $18.99 04/04/2024 Food and Beverage Undisputed 01/23/2026 1105229719 CMS
AstraZeneca Pharmaceuticals LP $16.29 07/18/2024 Food and Beverage Undisputed 01/23/2026 1104453840 CMS
AstraZeneca Pharmaceuticals LP $17.48 10/17/2024 Food and Beverage Undisputed 01/23/2026 1105537681 CMS
AstraZeneca Pharmaceuticals LP $13.74 10/29/2024 Food and Beverage Undisputed 01/23/2026 1104765992 CMS
Novartis Pharmaceuticals Corporation $1.91 01/11/2024 Food and Beverage Undisputed 01/23/2026 1087177397 CMS
Novartis Pharmaceuticals Corporation $1.97 03/06/2024 Food and Beverage Undisputed 01/23/2026 1087177403 CMS
Novartis Pharmaceuticals Corporation $20.19 04/04/2024 Food and Beverage Undisputed 01/23/2026 1087177399 CMS
Novartis Pharmaceuticals Corporation $3.86 04/24/2024 Food and Beverage Undisputed 01/23/2026 1087177409 CMS
Novartis Pharmaceuticals Corporation $3.29 05/08/2024 Food and Beverage Undisputed 01/23/2026 1087177411 CMS
Novartis Pharmaceuticals Corporation $18.68 05/08/2024 Food and Beverage Undisputed 01/23/2026 1087177413 CMS
Novartis Pharmaceuticals Corporation $2.88 05/20/2024 Food and Beverage Undisputed 01/23/2026 1087177417 CMS
Novartis Pharmaceuticals Corporation $24.74 05/22/2024 Food and Beverage Undisputed 01/23/2026 1087177415 CMS
Novartis Pharmaceuticals Corporation $20.17 06/06/2024 Food and Beverage Undisputed 01/23/2026 1087177419 CMS
Novartis Pharmaceuticals Corporation $2.32 06/13/2024 Food and Beverage Undisputed 01/23/2026 1087177423 CMS
Novartis Pharmaceuticals Corporation $4.55 07/25/2024 Food and Beverage Undisputed 01/23/2026 1087177425 CMS
Novartis Pharmaceuticals Corporation $3.80 08/14/2024 Food and Beverage Undisputed 01/23/2026 1087177427 CMS
Novartis Pharmaceuticals Corporation $6.38 08/15/2024 Food and Beverage Undisputed 01/23/2026 1087177433 CMS
Novartis Pharmaceuticals Corporation $3.88 08/28/2024 Food and Beverage Undisputed 01/23/2026 1087177435 CMS
Novartis Pharmaceuticals Corporation $4.10 09/11/2024 Food and Beverage Undisputed 01/23/2026 1087177437 CMS
Novartis Pharmaceuticals Corporation $19.45 09/18/2024 Food and Beverage Undisputed 01/23/2026 1087177443 CMS
Novartis Pharmaceuticals Corporation $4.26 09/26/2024 Food and Beverage Undisputed 01/23/2026 1087177441 CMS
Novartis Pharmaceuticals Corporation $4.69 10/24/2024 Food and Beverage Undisputed 01/23/2026 1087177447 CMS
Novartis Pharmaceuticals Corporation $4.21 11/19/2024 Food and Beverage Undisputed 01/23/2026 1087177451 CMS
Novartis Pharmaceuticals Corporation $3.84 12/10/2024 Food and Beverage Undisputed 01/23/2026 1087177455 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.